Therapeutic Potential of the Inhibition of the Retinoic Acid Hydroxylases CYP26A1 and CYP26B1 by Xenobiotics

E-ISSN： 1873-4294|13|12|1402-1428

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.13, Iss.12, 2013-06, pp. : 1402-1428

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of CYP26 enzymes in retinoic acid clearance

By Thatcher Jayne E Isoherranen Nina

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 875-886

Informa Healthcare

Access to resources Recommend Favorite

Prospective Teratology of Retinoic Acid Metabolic Blocking Agents (RAMBAs) and Loss of CYP26 Activity

Current Pharmaceutical Design, Vol. 13, Iss. 29, 2007-10 ,pp. : 3020-3037

Bentham Science Publishers

Access to resources Recommend Favorite

Co-Induction of CYP3A12 and 3A26 in Dog Liver Slices by Xenobiotics: Species Difference Between Human and Dog CYP3A Induction

Drug Metabolism Letters, Vol. 3, Iss. 1, 2009-01 ,pp. : 61-66

Bentham Science Publishers

Access to resources Recommend Favorite

In Vitro Inhibition of Rat CYP1A1 and CYP1A2 by Piceatannol, a Hydroxylated Metabolite of trans-Resveratrol

Drug Metabolism Letters, Vol. 1, Iss. 1, 2007-01 ,pp. : 13-16

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Procarcinogen Activating Enzyme CYP1A2 Activity and Free Radical Formation by Caffeic Acid and its Amide Analogues

Drug Metabolism Letters, Vol. 10, Iss. 3, 2016-09 ,pp. : 187-194

Bentham Science Publishers

Access to resources Recommend Favorite